Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Medical Journal ; (24): 172-176, 2011.
Artículo en Inglés | WPRIM | ID: wpr-321475

RESUMEN

<p><b>BACKGROUND</b>Both repaglinide and gliclazide are insulin secretagogues widely used in the treatment of type 2 diabetes. They stimulate insulin secretion through distinct mechanisms and may benefit patients from different aspects. The present study was to evaluate the effects of repaglinide or gliclazide on glycaemic control, insulin secretion, and lipid profiles in type 2 diabetes patients.</p><p><b>METHODS</b>A total of 47 newly diagnosed type 2 diabetes patients were randomized 1:1 to receive a 4-week treatment with repaglinide or gliclazide. The standard mixed meal tolerance test was performed before and after the treatment. Plasma glucose (PG), insulin concentration, and lipid profiles were measured. The area under insulin concentration curve (AUC(ins)) and the early-phase insulin secretion index (ΔI(30)/ΔG(30)) were calculated.</p><p><b>RESULTS</b>After the trial, fasting and postprandial PG and postprandial insulin improved significantly in both groups (P < 0.05). The maximum insulin concentration occurred earlier in the repaglinide group than that in the gliclazide group. AUC(ins) increased in both groups (P < 0.05), but no significant difference was found between groups. ΔI(30)/ΔG(30) increased in both groups (P < 0.05), especially in the repaglinide group (P < 0.05). Triglyceride and total cholesterol decreased significantly in the repaglinide group in some time points, while no significant change was observed in the gliclazide group.</p><p><b>CONCLUSIONS</b>Repaglinide and gliclazide had similar effects on glycaemic control and total insulin secretion, while repaglinide had more effects on improvements in β-cell function and lipid metabolism.</p>


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Glucemia , Carbamatos , Usos Terapéuticos , Colesterol , Sangre , Diabetes Mellitus Tipo 2 , Sangre , Quimioterapia , Metabolismo , Ayuno , Sangre , Gliclazida , Usos Terapéuticos , Hipoglucemiantes , Usos Terapéuticos , Insulina , Secreciones Corporales , Piperidinas , Usos Terapéuticos , Periodo Posprandial , Resultado del Tratamiento , Triglicéridos , Sangre
2.
Journal of Central South University(Medical Sciences) ; (12): 238-244, 2008.
Artículo en Chino | WPRIM | ID: wpr-814089

RESUMEN

OBJECTIVE@#To determine the effect of different concentrations of glucose on the differentiation of 3T3-L(1) and the expression of insig-1 and insig-2 mRNA, and to explore the effect of insulin-induced gene in the differentiation and formation of adipocytes and lipogenesis.@*METHODS@#The 3T3-L(1) cells were induced to differentiate in high glucose concentration (25 mol/L G.S), low glucose concentration (5.5 mol/L G.S), and mannitol (19.5 mol/L Mannitol +5.5 mol/L G.S), respectively. The differentiation of 3T3-L(1) cells was examined by oil red "O" straining, and the expression of insig-1,insig-2 mRNA and AP2 mRNA was examined by RT-PCR and in situ hybridization.@*RESULTS@#With the differentiation of 3T3-L(1) cells, the expression of insig-1 and insig-2 mRNA was gradually up-regulated. The expression of insig-1 and insig-2 mRNA significantly increased while AP(2) mRNA decreased in the low glucose concentration inducing group and mannitol inducing group. In the high glucose concentration inducing group, the cell differentiation was poor (P<0.05). There was no difference between the low glucose concentration and the mannitol group in the differentiation of 3T3-L(1) cells, and in the expression of insig-1 and insig-2 and AP(2) mRNA.@*CONCLUSION@#Different concentrations of glucose may influence the cell differentiation and the low glucose concentration promotes insig-1 and insig-2 gene expression, which may lead to the inhibition of the differentiation and lipogenesis of preadipocytes.


Asunto(s)
Animales , Ratones , Células 3T3-L1 , Diferenciación Celular , Relación Dosis-Respuesta a Droga , Glucosa , Farmacología , Proteínas de la Membrana , Genética , ARN Mensajero , Genética
3.
Journal of Central South University(Medical Sciences) ; (12): 36-40, 2007.
Artículo en Chino | WPRIM | ID: wpr-813940

RESUMEN

OBJECTIVE@#To evaluate the expression of hCTLA4-Ig and their biological function in newborn porcine islets (NPIs) transfected with AAV-hCTLA4-Ig.@*METHODS@#Cultured NPIs were transfected with AAV-hCTLA4-Ig. The expression of CTLA4-Ig in these NPIs was assayed by RT-PCR and immunocytochemistry. The levels of IL-2, IFN-gamma, and TNF-alpha in the culture medium were assayed by ELISA after these cells the co-cultured with human. The response of glucose-stimulated insulin secretion was observed in the transgene group and the control group.@*RESULTS@#The expressions of CTLA4-Ig mRNA and protein were detected in the transgene group. The levels of cytokines were obviously lower in the transgene group than those in the control group (P0.05).@*CONCLUSION@#AAV mediated hCTLA4-Ig expression in NPIs could inhibit T lymphocyte to produce cytokines, while the endocrine functions of the NPIs were not significantly affected.


Asunto(s)
Animales , Humanos , Animales Recién Nacidos , Antígenos CD , Genética , Antígenos de Diferenciación , Genética , Antígeno CTLA-4 , Células Cultivadas , Dependovirus , Genética , Ensayo de Inmunoadsorción Enzimática , Expresión Génica , Fragmentos Fc de Inmunoglobulinas , Genética , Inmunohistoquímica , Interferón gamma , Interleucina-2 , Islotes Pancreáticos , Biología Celular , Alergia e Inmunología , Metabolismo , Proteínas Recombinantes de Fusión , Genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Porcinos , Transfección , Factor de Necrosis Tumoral alfa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA